KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy

BACKGROUND AND PURPOSE: KRAS and BRAF are mutated in 35% and 10% of colorectal cancers, respectively. However, data specifically for locally advanced rectal cancers are scarce, and the frequency of KRAS mutations in codons 61 and 146 remains to be established. MATERIALS AND METHODS: DNA was isolated...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Radiother Oncol
Auteurs principaux: Gaedcke, Jochen, Grade, Marian, Jung, Klaus, Schirmer, Markus, Jo, Peter, Obermeyer, Christoph, Wolff, Hendrik A., Herrmann, Markus K., Beissbarth, Tim, Becker, Heinz, Ried, Thomas, Ghadimi, Michael
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373270/
https://ncbi.nlm.nih.gov/pubmed/19913317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2009.10.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires